117 Broadway
Unit 4
Nedlands, WA 6009
Australia
61 8 9329 3396
https://argenica.com.au
Sector(s): Healthcare
Industry: Biotechnology
Full-time employees:
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Dr. Liz Dallimore B.Sc., M.B.A., Ph.D. | CEO, MD & Director | 276.25k | N/A | N/A |
Ms. Emma Waldon | CFO & Company Secretary | N/A | N/A | 1976 |
Prof. Bruno Philip Meloni | Chief Scientific Officer | N/A | N/A | N/A |
Argenica Therapeutics Limited engages in the research and development of a neuroprotective therapeutic drug in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate use to protect brain cells and reduce cell death during a stroke and other types of neural injuries. Argenica Therapeutics Limited was incorporated in 2019 and is based in Nedlands, Australia.
Argenica Therapeutics Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.